Evaluation of short-term treatment with 30 mg of quazepam in insomniac outpatients.
In a short-term clinical study, 60 insomniac outpatients were randomly assigned to receive either 30 mg of quazepam or placebo orally for five consecutive nights. All measures of sleep quazepam-treated patients had better sleep from the first night of treatment onward. Quazepam is a safe and effective hypnotic agent, and its efficacy is manifested on the first night of administration.
D000328:Adult; D014151:Anti-Anxiety Agents; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*
D014151:Anti-Anxiety Agents; D006993:Hypnotics and Sedatives; D001569:Benzodiazepines; C025130:quazepam